Status:
COMPLETED
Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis Patients
Lead Sponsor:
Kufa University
Conditions:
Hyperphosphataemia
Phosphorus
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Raised phosphate levels in the blood (hyperphosphatemia) are frequently observed in hemodialysis patients with chronic kidney failure. In addition to increasing the risk of life threatening complicati...
Detailed Description
this study occurred from October 2024 to January 2025 at the Hemodialysis Unit in the Department of Nephrology at Al-Sader Medical Teaching Hospital. After screening and applying exclusion criteria, a...
Eligibility Criteria
Inclusion
- Males and females aged 18-60 years
- Stage 5 CKD patients on hemodialysis
- Receiving ≥2 weekly dialysis sessions for ≥2 months
- Written informed consent provided
- Ability (patient/caregiver) to read, write, and speak Arabic
Exclusion
- Age \<18 or \>60
- Receiving \<2 dialysis sessions per week or \<2 months duration
- Refusal or inability to provide consent
- Severe mental illness or cognitive impairment
- Acute illness, infection, or hospitalization at enrollment
- Malabsorption conditions or prior GI surgery
- Noncompliance with medication or dialysis regimen
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07180069
Start Date
October 1 2024
End Date
January 1 2025
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of kufa
Najaf, Iraq, 24001